Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules

Seed financing will drive commercial growth for Cambrium’s first product, NovaColl™, and accelerate expansion into new industries BERLIN, Oct. 31, 2023 (Korea Bizwire) – Synthetic biology startup Cambrium announces €8 Million in Seed financing, led by Essential Capital, along with SNR, Valor Equity Partners, and HOF Capital. The Berlin-based company brings novel molecules with previously [...]